Corporate Development Manager
Share role
The recipient sees their own assessment. Your profile and score are not shared.
About the role
H1 seeks a Corporate Development Manager for a US Remote role listed as hybrid. The position owns financial activities across M&A and strategic transactions, including target screening, valuation, diligence, modeling, negotiations, execution and integration planning. Applicants need 3+ years in investment banking, private equity, corporate development or transaction advisory, plus strong modeling, analytical, commercial and cross-functional skills. Life Sciences or HealthTech experience is a plus. Compensation is $150,000–$205,000 annually plus equity.
Key requirements
- • At least 3 years of relevant experience
- • Required skills: Financial modeling, Three-statement financial modeling, Financial analysis, Strategic analysis, M&A evaluation, Transaction execution, Financial due diligence, Synergies analysis, Pro-forma financial modeling, Cross-functional project management, Negotiation, Senior leadership communication, Relationship building
Opportunity details
- • Workplace: Hybrid
- • Posted: Oct 16, 2026
- • Deadline: Nov 16, 2026
- • Original advert language: English
Full vacancy
HealthRoleIQ regularly verifies this opportunity against the employer’s posting and highlights the details relevant to your match.
See original vacancy ↗Employer’s role description
Job title: Corporate Development Manager
Department: Finance
Team: Finance
Location: US Remote
All locations: US Remote
Work type: Full time
Workplace type: hybrid
At H1, we believe access to the best healthcare information is a basic human right. Our mission is to provide a platform that can optimally inform every doctor interaction globally. This promotes health equity and builds needed trust in healthcare systems. To accomplish this our teams harness the power of data and AI-technology to unlock groundbreaking medical insights and convert those insights into action that result in optimal patient outcomes and accelerates an equitable and inclusive drug development lifecycle.